Skip to main content

Stallings Robert W's Form 4/A amendment

Amended

Texas Capital Bancshares Inc (TCBI) · filed Apr 27, 2023

Accession no.
0001077428-23-000106
Filed
Apr 27, 2023
Trade date
Apr 24, 2023
Filing delay
3 days
Rule 10b5-1 plan
Not checked
Original filed
Apr 25, 2023

This filing lists 1 non-derivative transaction. It carries over 3 transactions from the original filing that it did not restate. Open-market purchases total $1.15M. It was filed 3 days after the trade.

This amendment restates part of 0001077428-23-000104 (filed Apr 25, 2023). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Stallings Robert WCIK 0000900764Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 24, 2023Common StockPPurchaseAcquired+15,000$51.44F2+$771,600197,000Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001077428-23-000104 (filed Apr 25, 2023).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001077428-23-000104
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 21, 2023Common StockPPurchaseAcquired+5,000$52.15F1+$260,750187,000Direct
Apr 21, 2023Depositary Shares for Series B Preferred StockPPurchaseAcquired+2,000$19.61F2+$39,22052,000Indirect
Apr 24, 2023Depositary Shares for Series B Preferred StockPPurchaseAcquired+4,000$20.28F5+$81,12056,000Indirect

Footnotes on the original

The footnotes that the prices of these transactions refer to on the original filing.

F1

The stated price represents the average based on prices ranging from $51.90 to $52.50. Upon request from the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Referenced by the price of 1 transaction in Table I.

F2

The stated price represents the average based on prices ranging from $19.56 to $19.66. Upon request from the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Referenced by the price of 1 transaction in Table I.

F5

The stated price represents the average based on prices ranging from $20.10 to $20.49. Upon request from the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Referenced by the price of 1 transaction in Table I.

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Reflects a correction to the timely-reported purchase on April 21, 2023 to properly reflect the number of total shares purchased on such date, which was overstated by 1,000 shares.

F2

The stated price represents the average based on prices ranging from $51.15 to $52.50. Upon request from the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)